Evidence map›Paper›PMID 29531581›Full record

ArticleOpen access Macedonian journal of medical sciences2018

Evaluation of Combined Use of Temocillin Disk and Mastdisks Inhibitor Combination Set Against Polymerase Chain Reaction for Detection of Carbapenem-Resistant

Omnia A Shaker, Howayda E Gomaa, Shereen A ElMasry, Rania M Abdel Halim, Amany H Abdelrahman, Jackline S Kamal

Abstract read
In one paragraph

Article in Open access Macedonian journal of medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Clinical Predispositions, Features, and Outcomes of Infections with Carbapenem-resistantIndian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2025
    Article
  6. Article
  7. Article
  8. Clonal Dissemination of KPC-2, VIM-1, OXA-48-ProducingPolish journal of microbiology · 2021
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Omnia A ShakerClinical Pathology Department - Faculty of Medicine - Ain Shams University, Cairo, Egypt.
Howayda E GomaaClinical Pathology Department -National Research Centre - Egypt, Cairo, Egypt.
Shereen A ElMasryClinical Pathology Department - Faculty of Medicine - Ain Shams University, Cairo, Egypt.
Rania M Abdel HalimClinical Pathology Department - Faculty of Medicine - Ain Shams University, Cairo, Egypt.
Amany H AbdelrahmanClinical Pathology Department -National Research Centre - Egypt, Cairo, Egypt.
Jackline S KamalClinical Pathology Department -National Research Centre - Egypt, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo evaluate the diagnostic performance of MDI and temocillin disk (30 μg) for detection of carbapenem-resistant MATERIAL AND

methodsFifty specimens submitted to the Microbiology Laboratory of Ain Shams University Hospitals and showed resistance to carbapenem drugs through routine culture and susceptibility testing, were assessed by both temocillin disk (30 μg) and MDI set to detect carbapenem-resistant

resultsOur work revealed that most of the CPE isolates were Klebsiella species (62%) followed by

conclusionAdding Temocillin disk to Mastdisks ID inhibitor combination set provides a simple, easy, rapid and highly sensitive test that can be used for screening and classification of carbapenem-resistant

Indexed as

CarbapenemasesEnterobacteriaceaeMastdisks inhibitorTemocillin

Identifiers

PMID29531581
PMCPMC5839425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.